As Politicians Argue About China, US Patients Find Cutting-Edge Treatment There By Arthur Allen Oct. 20, 2026

https://kffhealthnews.org/health-industry/china-cancer-drugs-foreign-travel-pharma-biotech-fda-regulation-clinical-trials/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_1VXYODtQvsOsYFHREnTOOGHKEht3655235eIkL0Mu9VgXNCo30shXEk-jY1QXs5KkcOt5Kez-9VueYa5pZD3yOwBPUQ&_hsmi=445129502&utm_content=445129502&utm_source=hs_email KFF Health News: As Politicians Argue About China, US Patients Find Cutting-Edge Treatment There Until recently, a Manhattanite might venture no more than a few dozen blocks to find the world’s most sophisticated cancer treatment. Cutting-edge American medicines have helped reduce the U.S. cancer death rate by about a third since 1990, and New York City hospitals deliver some of the best care in the country. But in January 2025, the city’s health systems had no good options for Debbie Doppelt, a 60-year-old jeweler with an unusual form of lung cancer that mostly afflicts nonsmokers like her. (Allen, 10/20)